News
EMA is good for the Netherlands’ innovation climate
The relocation of the European Medicines Agency (EMA) to Amsterdam will provide a boost to the region as a location for international and knowledge-intensive companies to establish themselves. The Agency determines which medicines are granted access to the European market. There are many medical sector companies that will be pleased to be based close to the EMA. It is therefore expected that some of those companies will follow the EMA to our country. Continue reading
IP Academy 2018
In early 2018, V.O. will once again be organising two separate day-long IP courses under the title of the ‘IP Academy’. These day-long events are aimed at IP managers and professionals responsible for IP policy. The basic course will be held on Thursday, 25 January and is aimed at those who deal with IP on a regular basis, but are not yet sufficiently familiar with all the necessary ‘ins and outs’. Continue reading